{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:30:42Z","timestamp":1758349842309,"version":"3.44.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality globally, and ranks fifth in terms of incidence. It primarily affects males and has a high prevalence in Asia. Risk factors include hepatitis B and C, liver cirrhosis, nonalcoholic fatty liver disease (NAFLD), and alcohol consumption. Late-stage diagnosis results in a poor survival rate of approximately 20%, underscoring the need for early detection methods to improve the survival rates. This study aimed to identify prognostic biomarkers for HCC through bioinformatic analysis of microarray datasets, providing insights into potential therapeutic targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed five microarray datasets, comprising 402 HCC samples and 121 control samples. To identify relevant biological pathways, we conducted differential gene expression, Gene Ontology (GO), and KEGG pathway enrichment analyses. We identified hub genes and quantitatively assessed transcription factors and microRNAs targeting these genes. Additionally, molecular docking and dynamic simulations (100 ns) were used to identify potential drug candidates capable of inhibiting the activity of differentially expressed hub genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our bioinformatic approach identified several promising HCC biomarkers. Among these, CDK1\/CKS2 was identified as a key therapeutic target, with a regulatory role in HCC pathogenesis, suggesting its potential for further investigation. Digoxin (DB00390) has been highlighted as a potential repurposed drug candidate because of its favorable drug-likeness and stability, as confirmed by virtual screening, ADMET analysis, molecular docking study and dynamic simulations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study enhances our understanding of HCC biology and offers new insights into drug interactions. It presents several promising biomarkers for the early diagnosis, prognosis, and therapy. Further investigation into CDK1\/CKS2 as a therapeutic target and the role of the identified biomarkers could contribute to improved diagnostic and therapeutic strategies for HCC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbinf.2025.1567748","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:28:50Z","timestamp":1758259730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and therapeutic investigation of biomarker genes underpinning hepatocellular carcinoma: an in silico study utilising molecular docking and dynamics simulation"],"prefix":"10.3389","volume":"5","author":[{"given":"Jishnu","family":"Ghosh","sequence":"first","affiliation":[]},{"given":"Abdullah M.","family":"Alshahrani","sequence":"additional","affiliation":[]},{"given":"Aritra","family":"Palodhi","sequence":"additional","affiliation":[]},{"given":"Debarghya","family":"Bhattacharyya","sequence":"additional","affiliation":[]},{"given":"Subhadip","family":"Das","sequence":"additional","affiliation":[]},{"given":"Sunil Kanti","family":"Mondal","sequence":"additional","affiliation":[]},{"given":"Abul","family":"Kalam","sequence":"additional","affiliation":[]},{"given":"S. Rehan","family":"Ahmad","sequence":"additional","affiliation":[]},{"given":"Chittabrata","family":"Mal","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"B1","first-page":"1","article-title":"Molecular dynamic simulations and molecular docking as a potential way for designed new inhibitor drug without resistance","volume":"21","author":"Aghajani","year":"2022","journal-title":"Tanaffos"},{"key":"B2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s13197-022-05594-y","article-title":"Molecular dynamic (in silico) modeling of structure-function of glutelin type-B 5-like from proso millet storage protein: effects of temperature and pressure","volume":"60","author":"Akharume","year":"2023","journal-title":"J. food Sci. Technol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1473398","DOI":"10.3389\/fchem.2024.1473398","article-title":"Development of novel CDK9 and CYP3A4 inhibitors for cancer therapy through field and computational approaches","volume":"12","author":"Alsfouk","year":"2024","journal-title":"Front. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/cbin.12145","article-title":"Noncoding RNAs and programmed cell death in hepatocellular carcinoma: significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate","volume":"48","author":"Arefnezhad","year":"2024","journal-title":"Cell. Biol. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.sjbs.2023.103753","article-title":"Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach","volume":"30","author":"Bagewadi","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"gkae303","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA a Cancer J. Clin."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1535-7163.mct-08-0836","article-title":"AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts","volume":"8","author":"Byth","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.21037\/jgo-22-825","article-title":"Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions","volume":"13","author":"Cheng","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3390\/molecules25112615","article-title":"The study on the hERG blocker prediction using chemical fingerprint analysis","volume":"25","author":"Choi","year":"2020","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/cancers14081902","article-title":"Proteoglycans in cancer: friends or enemies? A special focus on hepatocellular carcinoma","volume":"14","author":"Dituri","year":"2022","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"W331","DOI":"10.1093\/nar\/gkx312","article-title":"LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands","volume":"45","author":"Dodda","year":"","journal-title":"Nucleic acids Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1021\/acs.jpcb.7b00272","article-title":"1.14* CM1A-LBCC: localized bond-charge corrected CM1A charges for condensed-phase simulations","volume":"121","author":"Dodda","year":"","journal-title":"J. Phys. Chem. B"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-1028-5-11","article-title":"An overview of CDK1\/CKS2-controlled targets and processes","volume":"5","author":"Enserink","year":"2010","journal-title":"Cell. Div."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12336","DOI":"10.1038\/ncomms12336","article-title":"Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma","volume":"7","author":"Eskiocak","year":"2016","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/open.202100178","article-title":"Computational Pharmacokinetics report, ADMET study and conceptual DFT\u2010based estimation of the chemical Reactivity properties of Marine Cyclopeptides","volume":"10","author":"Flores\u2010Holgu\u00edn","year":"2021","journal-title":"ChemistryOpen"},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neo.2017.01.010","article-title":"Digoxin plus trametinib therapy achieves disease control in BRAF wild-type metastatic melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Adv. protein Chem. Struct. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13321-019-0383-2","article-title":"SAR and QSAR modeling of a large collection of LD 50 rat acute oral toxicity data","volume":"11","author":"Gadaleta","year":"2019","journal-title":"J. Cheminformatics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3892\/ijo.2020.5070","article-title":"Digitoxin inhibits HeLa cell growth through the induction of G2\/M cell cycle arrest and apoptosis in vitro and in vivo","volume":"57","author":"Gan","year":"2020","journal-title":"Int. J. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41401-022-00996-2","article-title":"DrugRep: an automatic virtual screening server for drug repurposing","volume":"44","author":"Gan","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jcar.jcar_9_16","article-title":"Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J. Carcinog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jmb.2006.09.062","article-title":"How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding","volume":"365","author":"Gunasekaran","year":"2007","journal-title":"J. Mol. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fphar.2019.00434","article-title":"In silico ADME and toxicity prediction of ceftazidime and its impurities","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e26964","DOI":"10.1097\/md.0000000000026964","article-title":"Bioinformatics analysis of constructing a HCV-related hepatocellular carcinoma miRNA\u2013mRNA regulation network","volume":"100","author":"Hao","year":"2021","journal-title":"Medicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijo.2013.1951","article-title":"Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis","volume":"43","author":"Hishida","year":"2013","journal-title":"Int. J. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1158\/1078-0432.CCR-12-1641","article-title":"Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C","volume":"19","author":"Hodo","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"volume-title":"Drug clearance","year":"2024","author":"Horde","key":"B34"},{"key":"B35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbrc.2022.07.047","article-title":"HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression","volume":"623","author":"Hu","year":"2022","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"eaat0150","DOI":"10.1126\/scitranslmed.aat0150","article-title":"Systems biology\u2013based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma","volume":"10","author":"Huang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jceh.2019.01.004","article-title":"Hepatocellular carcinoma: etiology and current and future drugs","volume":"9","author":"Jindal","year":"2019","journal-title":"J. Clin. Exp. hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1073\/pnas.0408037102","article-title":"Potential energy functions for atomic-level simulations of water and organic and biomolecular systems","volume":"102","author":"Jorgensen","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1039\/d4ra05089d","article-title":"Incredible use of plant-derived bioactives as anticancer agents","volume":"15","author":"Kangra","year":"2025","journal-title":"RSC Adv."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41591-024-03486-6","article-title":"Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial","volume":"31","author":"Kurzeder","year":"2025","journal-title":"Nat. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/bioinformatics\/btab726","article-title":"Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning","volume":"38","author":"Li","year":"2022","journal-title":"Bioinformatics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"29302","DOI":"10.1074\/jbc.m403664200","article-title":"Involvement of Cdk5\/p25 in Digoxin-triggered prostate cancer cell apoptosis","volume":"279","author":"Lin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.26355\/eurrev_202101_24634","article-title":"FOXN2 suppresses the proliferation and invasion of human hepatocellular carcinoma cells","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. and Pharmacol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/dddt.s504671","article-title":"Unveiling the novel Anti-tumor potential of Digitonin, a Steroidal Saponin, in gastric cancer: a network pharmacology and experimental validation study","author":"Lu","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijsu.2020.04.043","article-title":"Emerging biomarkers in HCC patients: current status","volume":"82","author":"Marques","year":"2020","journal-title":"Int. J. Surg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","article-title":"Comparative protein structure modeling of genes and genomes","volume":"29","author":"Mart\u00ed-Renom","year":"2000","journal-title":"Annu. Rev. biophysics Biomol. Struct."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","article-title":"Analysis of protein folding simulation with moving root mean square deviation","volume":"63","author":"Maruyama","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"B49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. computer-aided drug Des."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e23082","DOI":"10.4161\/onci.23082","article-title":"Trial watch: cardiac glycosides and cancer therapy","volume":"2","author":"Menger","year":"2013","journal-title":"Oncoimmunology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1080\/07391102.2022.2069866","article-title":"GBP5 and ACSS3: two potential biomarkers of high-grade ovarian cancer identified through downstream analysis of microarray data","volume":"41","author":"Mitra","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B52","first-page":"701","article-title":"Radius of gyration is indicator of compactness of protein structure","volume":"42","author":"Miu","year":"2008","journal-title":"Mol. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e2152","DOI":"10.1002\/cnr2.2152","article-title":"Deciphering the molecular complexity of hepatocellular carcinoma: unveiling novel biomarkers and therapeutic targets through advanced bioinformatics analysis","volume":"7","author":"Moghimi","year":"2024","journal-title":"Cancer Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"152428","DOI":"10.1016\/j.prp.2019.04.020","article-title":"Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation","volume":"215","author":"Ni","year":"2019","journal-title":"Pathology-Research Pract."},{"key":"B55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/08998280.2000.11927719","article-title":"Drug interactions due to cytochrome P450","volume":"13","author":"Ogu","year":"2000","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"22223","DOI":"10.1038\/srep22223","article-title":"Significant impact of miRNA\u2013target gene networks on genetics of human complex traits","volume":"6","author":"Okada","year":"2016","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3390\/cancers13102355","article-title":"Estrogen receptor-\u03b1 suppresses liver carcinogenesis and establishes sex-specific gene expression","volume":"13","author":"O\u2019Brien","year":"2021","journal-title":"Cancers"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e39918","DOI":"10.1371\/journal.pone.0039918","article-title":"Evaluating the effects of cutoffs and treatment of long-range electrostatics in protein folding simulations","volume":"7","author":"Piana","year":"2012","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nmeth.1818","article-title":"HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment","volume":"9","author":"Remmert","year":"2012","journal-title":"Nat. Methods"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e40134","DOI":"10.1097\/md.0000000000040134","article-title":"Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis","volume":"103","author":"Ren","year":"2024","journal-title":"Medicine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0022-2836(84)90231-6","article-title":"Solvent accessible surface area and excluded volume in proteins: Analytical equations for overlapping spheres and implications for the hydrophobic effect","volume":"178","author":"Richmond","year":"1984","journal-title":"J. Mol. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"838152","DOI":"10.3389\/fonc.2022.838152","article-title":"Mechanism of Phellodendron and Anemarrhena drug pair on the treatment of liver cancer based on network pharmacology and bioinformatics","volume":"12","author":"Ruan","year":"2022","journal-title":"Front. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1016952","DOI":"10.3389\/fonc.2022.1016952","article-title":"HCC biomarkers\u2013state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice","volume":"12","author":"Schlosser","year":"2022","journal-title":"Front. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"101024","DOI":"10.1016\/j.mgene.2022.101024","article-title":"LncRNA, miRNA and transcriptional co-regulatory network of breast and ovarian cancer reveals hub molecules","volume":"32","author":"Shil","year":"2022","journal-title":"Hum. Gene"},{"key":"B67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ebiom.2018.12.058","article-title":"Comprehensive molecular and immunological characterization of hepatocellular carcinoma","volume":"40","author":"Shimada","year":"2019","journal-title":"EBioMedicine"},{"key":"B68","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high\u2010quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4254\/wjh.v12.i9.558","article-title":"Biomarkers for hepatocellular cancer","volume":"12","author":"Singh","year":"2020","journal-title":"World J. Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2174\/1389201023666220628113452","article-title":"Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in hepatocellular carcinoma","volume":"24","author":"Su","year":"2023","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1089\/gtmb.2019.0242","article-title":"In silico identification of crucial genes and specific pathways in hepatocellular cancer","volume":"24","author":"Sun","year":"2020","journal-title":"Genet. Test. Mol. biomarkers"},{"key":"B72","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s12032-010-9554-8","article-title":"Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis","volume":"28","author":"Tsiambas","year":"2011","journal-title":"Med. Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","article-title":"Biomarkers for the early diagnosis of hepatocellular carcinoma","volume":"21","author":"Tsuchiya","year":"2015","journal-title":"World J. Gastroenterology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1517\/17425255.1.2.175","article-title":"Caco-2 cell permeability assays to measure drug absorption","volume":"1","author":"Van Breemen","year":"2005","journal-title":"Expert Opin. Drug Metabolism and Toxicol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1158\/1078-0432.CCR-06-2236","article-title":"Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma","volume":"13","author":"Wang","year":"2007","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1186\/1471-2164-14-736","article-title":"Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC","volume":"14","author":"Wang","year":"2013","journal-title":"BMC genomics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.3892\/mmr.2018.8871","article-title":"Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1093\/bioinformatics\/btz213","article-title":"PgpRules: a decision tree based prediction server for P-glycoprotein substrates and inhibitors","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinformatics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fphar.2020.00186","article-title":"Digoxin enhances the anticancer effect on non-small cell lung cancer while reducing the cardiotoxicity of adriamycin","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11010-020-03927-z","article-title":"miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1","volume":"476","author":"Wang","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chembiol.2018.10.015","article-title":"Differences in the conformational energy landscape of CDK1 and CDK2 suggest a mechanism for achieving selective CDK inhibition","volume":"26","author":"Wood","year":"2019","journal-title":"Cell. Chem. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"106342","DOI":"10.1016\/j.bioorg.2023.106342","article-title":"Research progress on the structure and biological diversities of 2-phenylindole derivatives in recent 20 years","volume":"132","author":"Wu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"144017","DOI":"10.1016\/j.gene.2019.144017","article-title":"SOX9 promotes nasopharyngeal carcinoma cell proliferation, migration and invasion through BMP2 and mTOR signaling","volume":"715","author":"Xiao","year":"2019","journal-title":"Gene"},{"key":"B84","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.drudis.2013.02.008","article-title":"Considering the impact drug-like properties have on the chance of success","volume":"18","author":"Yusof","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B85","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1007\/s13277-015-3582-0","article-title":"miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumor Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8964015","article-title":"Cyclin\u2010dependent kinase regulatory subunit 2 indicated poor prognosis and facilitated aggressive phenotype of hepatocellular carcinoma","volume":"2019","author":"Zhang","year":"2019","journal-title":"Dis. Markers"},{"key":"B87","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4236\/jct.2021.124019","article-title":"Identification of hub genes associated with hepatocellular carcinoma prognosis by bioinformatics analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41467-022-28618-9","article-title":"Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer","volume":"13","author":"Zhang","year":"","journal-title":"Nat. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"899969","DOI":"10.3389\/fonc.2022.899969","article-title":"ESR1 regulates the obesity-and metabolism-differential gene MMAA to inhibit the occurrence and development of hepatocellular carcinoma","volume":"12","author":"Zhang","year":"","journal-title":"Front. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"12349","DOI":"10.2147\/CMAR.S279194","article-title":"Prognostic and predictive value of a 15 transcription factors (TFs) Panel for hepatocellular carcinoma","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s10565-023-09813-w","article-title":"The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2\/M arrest via downregulation of MEK1\/2 phosphorylation in leukemia cells","volume":"39","author":"Zhou","year":"2023","journal-title":"Cell. Biol. Toxicol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e925289","DOI":"10.12659\/msm.925289","article-title":"CDK1, CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma","volume":"26","author":"Zou","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1567748\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:28:51Z","timestamp":1758259731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1567748\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":93,"alternative-id":["10.3389\/fbinf.2025.1567748"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1567748","relation":{},"ISSN":["2673-7647"],"issn-type":[{"type":"electronic","value":"2673-7647"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1567748"}}